VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
BBWI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BBWIBath & Body Works, Inc.
$16.06$3.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBBWIFinancials

Bath & Body Works, Inc. (BBWI) Income Statement

30Y historyFree accessUpdated daily

Revenue has declined for three consecutive quarters, with a 2.3% year-over-year drop in Q2 2026, while gross margin volatility (ranging from 41.0% to 46.7% over the past ten periods) suggests profitability improvements are driven by cost discipline rather than sustainable demand growth.

Income StatementBalance SheetCash FlowRatios

BBWI Income Statement

Annual statement

BBWI Income Statement

Bath & Body Works, Inc. (BBWI) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMJan'26Jan'25Jan'24Jan'23Jan'22Jan'21Jan'20Jan'19Jan'18Jan'17Jan'16Jan'15Jan'14Jan'13Jan'12Jan'11Jan'10Jan'09Jan'08Jan'07Jan'06Jan'05Jan'04Jan'03Jan'02Jan'01Jan'00Jan'99Jan'98Jan'97
Sales/Revenue7.21B7.29B7.31B7.43B7.56B7.88B6.43B5.41B13.24B12.63B12.57B12.15B11.45B10.77B10.46B10.36B9.61B8.63B9.04B10.13B10.67B9.7B9.41B8.93B8.45B8.42B9.08B9.77B9.36B9.19B8.64B
Revenue Growth %-15.64%-0.22%-1.64%-1.73%-4.09%22.51%19.04%-59.17%4.79%0.46%3.46%6.11%6.32%3%0.92%7.81%11.36%-4.54%-10.77%-5.03%10.02%3.09%5.31%5.79%0.26%-7.24%-7.02%4.28%1.92%6.29%9.69%
Cost of Goods Sold4.03B4.1B4.07B4.19B4.3B4.03B3.34B3.02B8.34B7.67B7.45B6.95B6.65B6.34B6.07B6.31B5.98B5.6B6.04B6.63B6.66B6.22B6.03B5.68B5.35B5.41B5.89B6.17B6.14B6.06B5.86B
COGS % of Revenue-56.26%55.74%56.44%56.94%51.09%51.88%55.84%62.99%60.74%59.24%57.18%58.02%58.89%58.06%60.85%62.23%64.92%66.76%65.37%62.39%64.12%64.09%63.61%63.36%64.19%64.92%63.19%65.55%65.92%67.77%
Gross Profit3.18B3.19B3.23B3.24B3.25B3.85B3.1B2.39B4.9B4.96B5.13B5.2B4.81B4.43B4.39B4.06B3.63B3.03B3.01B3.51B4.01B3.48B3.38B3.25B3.09B3.02B3.19B3.6B3.23B3.13B2.79B
Gross Margin %44.12%43.74%44.26%43.56%43.06%48.91%48.12%44.16%37.01%39.26%40.76%42.82%41.98%41.11%41.94%39.15%37.77%35.08%33.24%34.63%37.61%35.88%35.91%36.39%36.64%35.81%35.08%36.81%34.45%34.08%32.23%
Gross Profit Growth %--1.39%-0.06%-0.58%-15.56%24.52%29.7%-51.28%-1.21%-3.24%-1.52%8.24%8.56%0.98%8.11%11.73%19.91%0.73%-14.33%-12.56%15.32%3.02%3.91%5.07%2.59%-5.31%-11.4%11.43%3.03%12.39%17.39%
Operating Expenses1.97B2.06B1.97B1.95B1.88B1.85B1.49B1.35B3.66B3.23B3.12B3.01B2.85B2.69B2.81B2.82B2.34B2.16B2.29B2.4B2.84B2.49B2.35B2.29B2.26B2.12B2.35B2.69B2.54B2.44B2.14B
OpEx % of Revenue-28.3%26.93%26.26%24.85%23.42%23.19%24.92%27.66%25.58%24.83%24.78%24.93%24.93%26.9%27.2%24.35%24.99%25.3%23.67%26.59%25.71%24.99%25.61%26.71%25.17%25.91%27.52%27.15%26.53%24.73%
Selling, General & Admin1.97B2.06B1.97B1.95B1.88B1.85B1.49B1.35B3.56B3.23B3.12B3.01B2.85B2.69B2.72B2.7B2.34B2.17B2.31B2.62B2.84B2.49B2.35B2.29B2.22B2.29B2.34B2.42B2.26B2.12B1.85B
SG&A % of Revenue-28.3%26.93%26.26%24.85%23.42%23.19%24.92%26.92%25.58%24.83%24.78%24.93%24.93%26.01%26.03%24.35%25.09%25.56%25.81%26.59%25.71%24.99%25.61%26.31%27.19%25.8%24.74%24.09%23.12%21.38%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses0000000099M0000093M121M0-9M-23M-217M000034M-170M10M272M286M313.3M289.6M
Operating Income1.21B1.13B1.27B1.28B1.38B2.01B1.6B1.04B1.24B1.73B2B2.19B1.95B1.74B1.57B1.24B1.28B868M718M1.11B1.18B986M1.03B963M838M896M832M907M683.8M693.3M648.1M
Operating Margin %16.74%15.44%17.33%17.3%18.2%25.49%24.93%19.24%9.35%13.68%15.93%18.04%17.05%16.18%15.04%11.95%13.36%10.06%7.94%10.95%11.02%10.17%10.92%10.78%9.92%10.64%9.16%9.29%7.3%7.55%7.5%
Operating Income Growth %--11.06%-1.48%-6.61%-31.51%25.25%54.23%-15.93%-28.41%-13.73%-8.62%12.24%12.05%10.81%27.06%-3.58%47.93%20.89%-35.32%-5.61%19.27%-3.99%6.65%14.92%-6.47%7.69%-8.27%32.64%-1.37%6.97%5.9%
EBITDA1.39B1.38B1.55B1.55B1.6B2.37B2.13B1.63B1.83B2.3B2.52B2.65B2.39B2.15B1.96B1.63B1.68B1.26B1.09B1.46B1.49B1.28B1.36B1.25B1.15B1.17B1.1B1.18B969.8M1.01B937.7M
EBITDA Margin %19.33%18.93%21.19%20.92%21.12%30.09%33.03%30.12%13.8%18.2%20.05%21.8%20.87%19.96%18.76%15.72%17.46%14.61%12.11%14.43%13.98%13.25%14.46%14%13.59%13.93%12.15%12.07%10.36%10.95%10.85%
EBITDA Growth %-30.02%-10.85%-0.39%-2.69%-32.67%11.62%30.53%-10.89%-20.53%-8.81%-4.83%10.79%11.21%9.58%20.44%-2.92%33.07%15.16%-25.1%-2.01%16.11%-5.51%8.71%8.97%-2.13%6.35%-6.45%21.57%-3.66%7.35%4.43%
D&A (Non-Cash Add-back)187M254M282M269M221M363M521M588M590M571M518M457M438M407M389M391M394M393M377M352M316M299M333M288M310M277M271M272M286M313.3M289.6M
EBIT1.22B1.16B1.34B1.37B1.39B1.81B1.55B978M1.24B1.72B2.09B2.27B1.95B1.76B1.6B1.47B1.46B887M630M880M1.2B1.05B1.17B963M838M896M832M907M683.8M693.3M648.1M
Net Interest Income-269M-276M-312M-345M-348M-388M-432M-370M-385M-406M-394M-334M-324M-314M-316M-246M-181M-235M-163M-131M-77M-32M-28M00000000
Interest Income00000000000000002M2.37M18M18M25M62M30M00000000
Interest Expense269M276M312M345M348M388M432M370M385M406M394M334M324M314M316M246M183M237M181M149M102M94M58M00000000
Other Income/Expense-236M-244M-238M-264M-331M-586M-482M-432M-380M-416M-307M-258M-317M-297M-292M-11M-33M-218M-269M19M-79M-29M89M203M-1M-14M-107M-75M1.67B-292.9M27.1M
Pretax Income971M882M1.03B1.02B1.04B1.42B1.12B608M857M1.31B1.7B1.93B1.64B1.45B1.28B1.23B1.25B650M449M1.13B1.1B957M1.12B1.17B837M882M725M832M2.35B400.4M675.2M
Pretax Margin %13.47%12.1%14.07%13.74%13.82%18.05%17.44%11.25%6.47%10.39%13.49%15.91%14.28%13.42%12.25%11.84%13.01%7.53%4.97%11.14%10.28%9.87%11.86%13.05%9.91%10.47%7.98%8.52%25.11%4.36%7.81%
Income Tax190M233M230M143M251M348M257M148M213M329M538M681M594M543M528M377M446M202M233M411M422M291M411M449M341M376M318M371M305M183M241M
Effective Tax Rate %19.57%26.42%22.37%14.01%24.02%24.46%22.91%24.34%24.85%25.08%31.72%35.21%36.31%37.55%41.22%30.73%35.65%31.08%51.89%36.4%38.47%30.41%36.83%38.51%40.74%42.63%43.86%44.59%12.97%45.7%35.69%
Net Income781M649M798M878M800M1.33B844M-366M644M983M1.16B1.25B1.04B903M753M850M805M448M220M718M676M666M705M717M502M519M428M461M2.05B217.4M434.2M
Net Margin %10.83%8.9%10.92%11.82%10.58%16.91%13.12%-6.77%4.87%7.78%9.21%10.31%9.1%8.38%7.2%8.2%8.37%5.19%2.43%7.09%6.33%6.87%7.49%8.03%5.94%6.16%4.71%4.72%21.85%2.37%5.02%
Net Income Growth %-27.35%-18.67%-9.11%9.75%-39.98%57.94%330.6%-156.83%-34.49%-15.11%-7.58%20.25%15.39%19.92%-11.41%5.59%79.69%103.64%-69.36%6.21%1.5%-5.53%-1.67%42.83%-3.28%21.26%-7.16%-77.47%841.35%-49.93%-54.84%
Net Income (Continuing)781M649M798M878M794M1.07B865M460M644M983M1.16B1.25B1.04B903M753M850M805M448M216M718M675M666M705M717M496M506M407M461M2.05B217.4M434.2M
Discontinued Operations00006M258M-21M-826M00000000000000000000000
Minority Interest2M2M2M1M1M1M1M4M4M2M2M1M1M1M1M1M1M1M1M55M71M33M33M00177M143.09M119.01M110.9M102.1M67.3M
EPS (Diluted)3.873.073.613.833.434.883.00-1.332.313.423.984.223.503.052.542.702.421.370.651.891.681.661.471.360.961.160.910.934.150.390.77
EPS Growth %-24.55%-14.96%-5.74%11.66%-29.71%62.67%325.56%-157.58%-32.46%-14.07%-5.69%20.57%14.75%20.08%-5.93%11.57%76.64%110.77%-65.61%12.5%1.2%12.93%8.09%41.67%-17.24%27.47%-2.15%-77.59%964.1%-49.35%-42.54%
EPS (Basic)-3.073.623.893.454.963.04-1.332.333.464.054.323.573.052.542.882.511.390.661.911.711.701.501.380.981.180.950.984.250.390.78
Diluted Shares Outstanding202M211.61M221M229M233M273M281M276M276.16M287.42M291.06M296.79M297.96M296.07M296.77M314.31M332.87M326.76M337M380M402.38M411.45M479M527.21M522M447.41M470.33M495.7M493.13M557.44M563.9M
Basic Shares Outstanding201.99M211.61M220M225.94M232M269M278M276M276M287.06M286M290M292M296.06M296.46M295M321M322M335M375M395.32M401.76M470M519.57M510M439.83M450.53M470.41M481.53M557.44M556.67M
Dividend Payout Ratio-25.73%22.18%20.73%23.25%9%9.83%-103.42%69.79%109.5%93.46%66.31%38.65%192.43%134.59%184.84%43.08%91.36%31.62%35.21%36.34%102.7%29.01%29.88%24.86%29.8%28.2%6.07%60.03%24.94%

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Persistent top-line pressure despite margin gains

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Growth Decelerates Amidst Promotional Headwinds

Bath & Body Works' revenue trajectory has shifted to consistent year-over-year declines, with the most recent quarter showing a 2.3% drop, suggesting the post-pandemic normalization of demand and intense promotional activity are weighing on the top line.

The company's revenue growth has decelerated from modest positive territory in early 2025 to a sustained negative trend, with the last four quarters all showing year-over-year declines. This pattern indicates that the tailwinds from the sanitizer boom have fully faded, and the core fragrance and body care business is struggling to grow organically. The persistent negative growth, even as management raises guidance, implies that profitability improvements are being driven by cost control and margin management rather than sales momentum, which may not be sustainable long-term.

Gross Margin Volatility Masks Underlying Structural Pressure

Gross margins have exhibited significant quarterly volatility, ranging from 41.0% to 46.7% over the past ten periods, which appears driven by the timing of promotional events and input cost fluctuations rather than a stable structural improvement.

The wide swing in gross margins, particularly the dip to 41.3% in Q3 2025 followed by a rebound to 45.7% in Q4 2025, suggests the company's profitability is highly sensitive to its promotional calendar and inventory clearance cycles. While the current 45.7% margin is healthy relative to peers like Ulta (39.1%), the inconsistency indicates limited pricing power and a reliance on deep discounts to move product. This volatility makes it difficult to assess the true underlying margin profile and raises questions about the durability of the recent margin expansion.

Operating Leverage Erodes as SG&A Outpaces Gross Profit

Operating income growth has consistently lagged gross profit growth over the last several quarters, indicating that selling, general, and administrative expenses are consuming a larger share of revenue and limiting the company's ability to translate sales into profit.

In Q2 2026, gross profit grew by approximately 8.1% year-over-year, yet operating income only increased by 18.3%, a positive but decelerating trend compared to prior periods. More critically, SG&A as a percentage of revenue has remained elevated, hovering between 30-35%, which suggests that the company's cost structure is not scaling efficiently with its revenue base. This lack of operating leverage implies that future profit growth will be difficult to achieve without either accelerating top-line growth or implementing more aggressive cost-cutting measures.

Net Income Volatility Driven by Non-Operating Items

The company's net income has shown extreme volatility, swinging from a loss of $77 million in Q3 2025 to a profit of $403 million in Q4 2025, which appears to be driven by non-operating factors rather than core business performance.

The dramatic swings in net income, particularly the massive Q4 2025 profit, suggest that one-time items, tax adjustments, or non-operating gains are significantly impacting reported earnings. This volatility makes it challenging to assess the true underlying profitability of the business. Investors should focus on operating income as a more reliable measure of core performance, as the net income figure appears to be distorted by factors outside of the company's operational control.

SG&A Discipline Provides Offset to Revenue Decline

Management appears to be exercising cost discipline, with SG&A expenses declining year-over-year in recent quarters, which has been a key driver of improved operating margins despite the challenging revenue environment.

In Q2 2026, SG&A expenses decreased by approximately 1.4% year-over-year, which helped offset the 2.3% revenue decline and contributed to the significant earnings beat. This suggests that the company is successfully managing its overhead costs, particularly in areas like store labor and corporate expenses. However, the sustainability of this cost-cutting is questionable, as there may be limits to how much further SG&A can be reduced without impacting store operations or customer experience.

Margin Expansion May Mask Structural Demand Weakness

The strong earnings beat and raised guidance could be masking underlying demand weakness, as the company's profitability improvements appear to be driven by cost cuts and promotional timing rather than sustainable revenue growth.

While the Q2 2026 results were impressive, the fact that they occurred alongside a 2.3% revenue decline raises concerns about the quality of the earnings improvement. The company's ability to generate higher profits on lower sales suggests it may be sacrificing long-term brand equity through excessive promotions or cutting costs that could hurt future growth. Furthermore, the CEO's commentary about 'underlying business trends remain pressured' indicates that the core demand environment is still challenging, which could limit the upside from operational improvements.

BBWI — Frequently Asked Questions

Quick answers to the most common questions about buying BBWI stock.

What was Bath & Body Works, Inc.'s (BBWI) revenue in 2025?

For fiscal year 2025, Bath & Body Works, Inc. (BBWI) reported total revenue of $7.29B. This represents a 15.7% decline compared to $8.64B in 1996.

Is Bath & Body Works, Inc. (BBWI) profitable?

Bath & Body Works, Inc. (BBWI) is profitable, generating $649.0M in net income for the fiscal year ending 2025 with a net profit margin of 8.9%.

What is Bath & Body Works, Inc.'s operating profit margin?

Bath & Body Works, Inc. (BBWI) reported an operating income of $1.13B, resulting in an operating profit margin of 15.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Bath & Body Works, Inc.'s gross profit and gross margin?

Bath & Body Works, Inc. (BBWI) generated $3.19B in gross profit for the year, representing a gross profit margin of 43.7%. This demonstrates the company's core pricing power and production efficiency.